Clinical Trial Update: A Safety and Efficacy Study of XERMELO® + First-line Chemotherapy in Patients With Advanced Biliary Tract Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update for XERMELO in combination with first-line chemotherapy in advanced biliary tract cancer; the study is terminated with results posted in 20…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Tract Cancer

Drugs mentioned

• XERMELO (telotristat ethyl)

Snippet

Sponsor: TerSera Therapeutics LLC | Conditions: Biliary Tract Cancer (BTC) | Phase 2 | Status: TERMINATED | Results posted: 2023-04-19